Delivery Order SPE2DB22D3301-SPE2DB25FZ0WU
- Not listed
- The Defense Logistics Agency awarded a $14,428.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. The delivery order represents a typical...
- The Defense Logistics Agency (DLA) awarded a $14,428.06 delivery order to AmerisourceBergen Drug Corp for Tabrecta 200 mg tablets (56-tablet units) with a completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TABRECTA 200 mg tablets in quantities of 56 units. This is a firm fixed-price contract with a ceiling value of $14.4K and an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and represents a competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- This federal contract award is for the delivery of Tabrecta 200 mg tablets to the Defense Logistics Agency (DLA). The $6,547.42 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs. The contract has a completion date of November 20, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $12,868.60 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562954453 TABRECTA 200 MG TABLET UU 56S. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by December 21, 2023. No set-aside designation was applied to this order, which was awarded against an existing indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,094.84, is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 7, 2024. This delivery order does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $13,094.84. The order is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a completion date of March 21, 2024. This Delivery Order does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the supply of pharmaceutical products, including the medication TABRECTA 200 MG TABLET, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $13,094.84. It does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $21,325.14 and an ultimate completion date of September 30, 2025. This non-set-aside competitive award represents a child delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0WUDelivery Order
The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This non-set-aside, firm fixed-price contract is scheduled for completion by October 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1B global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of delivery orders with the Defense Logistics Agency across multiple therapeutic domains. The company's competitively awarded contracts demonstrate its capability to fulfill federal pharmaceutical requirements ranging from small-value transactions to substantial orders exceeding $45,000. This particular order for Tabrecta supports the Defense Health Agency and other federal healthcare systems through the comprehensive global pharmaceutical prime vendor program structure managed by DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 9/12/25 |